NeuroBell
PrivateLast Round
Seed
Dec 1, 2023
Total Funding Raised
$2.32M
Company Overview
NeuroBell operates in Healthcare & Life Sciences and is based in Cork. Its latest recorded funding round was a Seed round in December 2023.
NeuroBell is a medical devices company that develops a portable EEG monitoring device with automated, real-time seizure detection for newborns.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroBell Comparables
Compare NeuroBell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CergenX | 93% | |
| Epitel, Inc. | 76% | |
| Natus Medical Incorporated | 74% |
For institutional investors. Book with your work email.
NeuroBell Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroBell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Seed |
| Furthr VC | Seed |
| The MedTech Syndicate | Seed |
| Enterprise Ireland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2025
Grew 23% QoQ, from 13 to 16 employees.
- Dec 11, 2024
Grew 30% QoQ, from 10 to 13 employees.
For institutional investors. Book with your work email.
NeuroBell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroBell's valuation, stock price, and market status.
Is NeuroBell a public or private company?
NeuroBell is a private company.
What is the current stock price of NeuroBell?
NeuroBell is a private company, so its shares have no public market price. Caplight tracks NeuroBell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroBell worth (valuation)?
Valuation information for NeuroBell is not publicly available.
Can I buy NeuroBell stock?
NeuroBell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroBell's last funding round?
NeuroBell's most recent funding round was Seed on December 1, 2023.
Who are the main investors in NeuroBell?
Key investors in NeuroBell include Atlantic Bridge Capital, Furthr VC, The MedTech Syndicate.
Will NeuroBell IPO soon?
No public IPO plans have been announced for NeuroBell.
How can I track NeuroBell secondary market activity?
Caplight tracks bids, offers, and trades in NeuroBell's shares on secondary markets.